Cotrimoxazole Prophylaxis Discontinuation among Antiretroviral-Treated HIV-1-Infected Adults in Kenya: A Randomized Non-inferiority Trial.

Cotrimoxazole Prophylaxis Discontinuation among Antiretroviral-Treated HIV-1-Infected Adults in Kenya: A Randomized Non-inferiority Trial.

Cotrimoxazole (CTX) prophylaxis is recommended by the World Health Organization (WHO) for HIV-1-infected individuals in settings with high infectious disease prevalence. The WHO 2006 guidelines were developed prior to the scale-up of antiretroviral therapy (ART). The threshold for CTX discontinuatio...

Full description

Bibliographic Details
Main Authors: Christina S Polyak, Krista Yuhas, Benson Singa, Monica Khaemba, Judd Walson, Barbra A Richardson, Grace John-Stewart
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS Medicine
Online Access:http://europepmc.org/articles/PMC4701407?pdf=render

Internet

http://europepmc.org/articles/PMC4701407?pdf=render

Similar Items